REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Proxima Pharma Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing | Advertising Agencies | Management of Companies and Enterprises | Packaging and Labeling Services
Full name: Proxima Pharma Sp. z o.o. Profile Updated: May 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Proxima Pharma Sp. z o.o manufactures medicines, cosmetics, and optical lenses for scratch treatment. The company offers solutions for viskoelastic products used in treating joint degenerative disease in Europe and globally. Their products, including ARTHRUM H, ARTHRUM VISC 75, and SYNOVIUM HCS, aim to reduce prolonged pain and reactivate the joint by supplementing and increasing the viskoelastity of mazium fluid in an articular altered during the course of degenerative disease.

Headquarters
Ul. Chmielna 2/31
Warsaw; Mazowieckie; Postal Code: 00-020

Contact Details: Purchase the Proxima Pharma Sp. z o.o. report to view the information.

Website: http://www.proxima-pharma.pl

Basic Information
Total Employees:
Purchase the Proxima Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Proxima Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Proxima Pharma Sp. z o.o. report to view the information.
Incorporation Date:
June 25, 2008
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
55%
Purchase this report to view the information.
45%
Company Performance
Financial values in the chart are available after Proxima Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-4.78%▼
Total operating revenue
-5.4%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-9.49%▼
Total equity
2.71%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
8.81%▲
Quick Ratio
-0.06%▼
Cash Ratio
-0.11%▼

Similar companies

Mos Consulting Sp. z o.o.
 
Unilever Polska Sp. z o.o.
Doz S.A. Direct sp. k.
 
Bausch Health Poland Sp. z o.o.
PHUP Gniezno Szeszycki sp. k.
 
"Mgi Polska" Sp. z o.o.
Przedsiebiorstwo Produkcyjno-Uslugowo-Handlowe "Poldan" Sp. z o.o.
 
Meeratoo Sp. z o.o.
Its Group Sp. z o.o.
 
A.K.S.E.L. Sp. z o.o.
X-Karen Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo